News

Novavax says talks with FDA on COVID vaccine approval ongoing calming investor fears
Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.
COVID vaccine boosters called into question by FDA chief: ‘Void of data’
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
Knowridge Science Report2h
Combined flu and COVID vaccine shows strong immune response in older people
A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...
Novavax swings to profit, says talks with FDA on COVID vaccine approval ongoing
Novavax said on Thursday discussions with the U.S. health regulator on its COVID-19 shot are ongoing and a pathway to ...
Fewer than half of Americans trust FDA, CDC to do their job
Five years after the onset of the COVID-19 pandemic, 42 percent of people in the U.S. think federal health agencies are ...
The Japan Times3dOpinion
RFK Jr.’s new vaccine scrutiny is alarming
Robert F. Kennedy Jr., who oversees the FDA, intends to set new regulatory standards vaccine manufacturers couldn’t possibly ...
CIDRAP3dOpinion
Proposed system for vaccine approval, safety monitoring begs crucial questions
Proposed changes to the vaccine approval system deserve the same scrutiny. Press reports indicate that new vaccines will be ...
BioSpace3d
FDA Action Alert: GSK, Sanofi, Merck and More
On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...